Uyen Dinh
Psychiatric/Mental Health · Pittsburg, KSNPI 1568870145
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,513 of the $19,954 with a category attached, or 62.7%. AbbVie accounts for 73.5% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $12,890 and has fallen 88.4% since, to $1,491 in 2025. Among psychiatric/mental health clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 187 payments — averaging $106.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$15K
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Otsuka America Pharmaceutical, Inc.$923
- Johnson & Johnson$870
- Axsome Therapeutics, Inc.$390
- plus $1K from 13 others
What the payments were for
- Speaking & faculty fees$12,51363%
- Travel & lodging$1,4978%
- Food & beverage$5,89430%
- Education$510%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 40 | $14,671 |
| Alkermes, Inc. | 24 | $1,032 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $1,004 |
| Otsuka America Pharmaceutical, Inc. | 18 | $923 |
| Johnson & Johnson | 33 | $870 |
| Axsome Therapeutics, Inc. | 8 | $390 |
| Abbott | 2 | $217 |
| Supernus Pharmaceuticals, Inc. | 4 | $176 |
| Teva Pharmaceuticals USA, Inc. | 2 | $140 |
| Ironshore Pharmaceuticals Inc. | 2 | $101 |
| Sunovion Pharmaceuticals Inc. | 7 | $99 |
| E.r. Squibb & Sons, L.L.C. | 3 | $84 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $72 |
| Amgen | 2 | $53 |
| Corium, LLC | 2 | $41 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Noven Therapeutics, LLC | 1 | $19 |
| Neurocrine Biosciences, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,954 in reported general payments places this provider in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 58 | $86,387 |
| LybalviOlanzapine/Samidorphan Malate | 34 | $59,447 |
| Invega SustennaPaliperidone Palmitate | 16 | $52,486 |
| Abilify MaintenaAripiprazole | 11 | $23,982 |
| RexultiBrexpiprazole | 13 | $19,685 |
| Lurasidone Hcl | 59 | $15,219 |
| Paliperidone ErPaliperidone | 53 | $15,055 |
| TrintellixVortioxetine Hydrobromide | 23 | $12,259 |
| BelsomraSuvorexant | 27 | $12,025 |
| FetzimaLevomilnacipran Hcl | 15 | $8,165 |
| Chlorpromazine Hcl | 12 | $7,395 |
| Perphenazine | 12 | $5,964 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 37 | $3,438 |
| Clozapine | 22 | $3,304 |
| Oxcarbazepine | 51 | $2,781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar, Fetzima | $14,671 | $94,55373 claims |
| Alkermes, Inc.Lybalvi | $1,032 | $59,44734 claims |
| Johnson & JohnsonInvega Sustenna | $870 | $52,48616 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $923 | $43,66724 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $72 | $12,25923 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 404 psychiatric/mental health providers in Kansas.
Other psychiatric/mental health in Pittsburg
- Eric ThomasonPittsburg$333K
- Melissa JohnstonPittsburg$6K
- Belinda BagbyHutchinson$39K
- Hayley KnappWichita$31K
- Jennifer KubinBaldwin City$26K
- Louise MuhoziKansas City$14K
- Theresa MuellerOverland Park$14K
- Shiney ZchariaOlathe$14K
- Deborah MurphyWichita$13K
- Marijen AgaShawnee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.